Home/Filings/4/0001209191-24-000810
4//SEC Filing

Dorsey Brian 4

Accession 0001209191-24-000810

CIK 0001671858other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:42 PM ET

Size

5.6 KB

Accession

0001209191-24-000810

Insider Transaction Report

Form 4
Period: 2024-01-02
Dorsey Brian
Chief Operating Officer
Transactions
  • Award

    Stock option (right to buy)

    2024-01-02+350,000350,000 total
    Exercise: $5.58Exp: 2034-01-01Common Stock (350,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares will vest monthly thereafter over three years.

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001380762

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:42 PM ET
Size
5.6 KB